These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5705812)

  • 21. Anticonvulsant osteomalacia in epileptic outpatients.
    Hoikka V; Savolainen K; Alhava EM; Sivenius J; Karjalainen P; Parvianinen M
    Ann Clin Res; 1982 Jun; 14(3):129-32. PubMed ID: 7137882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary hydroxyproline excretion in comparison with other immunoinflammatory indices in progressive systemic sclerosis.
    Punzi L; Schivo P; Gambari PF; Todesco S
    Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2426-30. PubMed ID: 756739
    [No Abstract]   [Full Text] [Related]  

  • 23. Acquired nonfamilial osteomalaci. Factors in pathogenesis and the results of long-term treatment with oral phosphate.
    Litvak J; Contreras V; Oberhauser E; Armendaris R; Alliende I
    Am J Med; 1968 Mar; 44(3):474-82. PubMed ID: 5641307
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
    Hoikka V; Savolainen K; Karjalainen P; Alhava EM; Sivenius J
    Ann Clin Res; 1982 Apr; 14(2):72-5. PubMed ID: 6983324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intravenous vitamin D on bone and phosphate metabolism in osteomalacia.
    Bordier P; Hioco D; Rouquier M; Hepner GW; Thompson GR
    Calcif Tissue Res; 1969 Aug; 4(1):78-83. PubMed ID: 5344411
    [No Abstract]   [Full Text] [Related]  

  • 26. Occult anticonvulsant osteomalacia in North India.
    Marya RK; Khattar VP; Bansal RK
    Nutr Metab; 1979; 23(3):167-71. PubMed ID: 424084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HYPOPHOSPHATAEMIC OSTEOMALACIA IN THE ADULT WITH DEFECTIVE RENAL TUBULAR FUNCTION. A REPORT OF FOUR CASES, WITH SPECIAL MENTION OF THE EFFECTS OF MASSIVE DOSES OF VITAMIN D (CALCIFEROL).
    DE SEZE S; LICHTWITZ A; HIOCO D; BORDIER P; MIRAVET L
    Ann Rheum Dis; 1964 Jan; 23(1):33-44. PubMed ID: 14102710
    [No Abstract]   [Full Text] [Related]  

  • 28. [RENAL OSTEOPATHIES].
    REUTTER F
    Schweiz Med Wochenschr; 1964 Jun; 94():861-7. PubMed ID: 14250322
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hypophosphatemic vitamin-resistant osteomalacia associated with neurofibromatosis].
    Morlock G; Savary JP; Sebert JL; Durroux R; Gardiol JC
    Rev Rhum Mal Osteoartic; 1982 Feb; 49(2):125-30. PubMed ID: 6801751
    [No Abstract]   [Full Text] [Related]  

  • 30. Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease.
    Dibble JB; Sheridan P; Hampshire R; Hardy GJ; Losowsky MS
    Q J Med; 1982; 51(201):89-103. PubMed ID: 6981120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of the treatment of active osteoporosis on the urinary excretion of hydroxyproline].
    Rico Lenza H; del Rio Vázquez A; Vázquez Salamanica E; Espinos Pérez D
    Rev Clin Esp; 1979 Apr; 153(2):103-6. PubMed ID: 482672
    [No Abstract]   [Full Text] [Related]  

  • 32. Normocalcemic secondary hyperparathyroidism and malabsorption.
    Fischer JA; Binswanger U; Schenk R; Merz W; Kistler HJ
    Helv Med Acta; 1969 May; 35(1):30-42. PubMed ID: 5772693
    [No Abstract]   [Full Text] [Related]  

  • 33. [Physiopathological bases of phosphate therapy of osteomalacia].
    Caniggia A; Gennari C; Bencini M; Palazzuoli V; Cesari L; Borrello G
    Minerva Med; 1969 Mar; 60(19):803-19. PubMed ID: 5776063
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hypophosphatemic vitamin D resistant osteomalacia with parathyroid adenoma (author's transl)].
    Blanc D; Mouries D; Phelip X
    Sem Hop; 1980 Jan 18-25; 56(3-4):184-7. PubMed ID: 6244654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total urinary hydroxyproline excretion after administration of Vitamin D to patients with hypoparathyroidism.
    Mautalen CA
    J Clin Endocrinol Metab; 1970 Nov; 31(5):595-9. PubMed ID: 4919045
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism.
    Smith GR; Collinson PO; Kiely PD
    J Rheumatol; 2005 Apr; 32(4):684-9. PubMed ID: 15801026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diseases contributing to fragility of bone in patients with hip fractures.
    Alhava EM
    Ann Clin Res; 1974 Aug; 6(4):246-52. PubMed ID: 4429337
    [No Abstract]   [Full Text] [Related]  

  • 38. [The excretion of hydroxyproline and proline peptide in osteomalacia and osteoporosis].
    Dubovský J; Pacovský V; Silinková-Málková E
    Z Gesamte Inn Med; 1966 Apr; 21(8):231-4. PubMed ID: 5985507
    [No Abstract]   [Full Text] [Related]  

  • 39. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bone diseases following gastric resection].
    Fourman P; Morgan DB; Pulvertaft CN
    Z Gesamte Inn Med; 1968 Mar; 23(6):165-8. PubMed ID: 5727295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.